查看購物車
  • Japanese
封面
市場調查報告書
商品編碼
2003238

人工水晶體市場（2026）：2025年至2031年全球市場分析

2026 IOL Market Report: Global Analysis for 2025 to 2031
出版日期: | 出版商: Market Scope, LLC | 英文 | 商品交期: 最快1-2個工作天內

價格
簡介目錄

什麼是新的：

《2026 年人工水晶體市場報告》是迄今為止最全面、最具策略性洞察力的版本，其中包含更詳細的區域分析、新的技術資訊以及對重塑全球白內障市場的結構性因素的廣泛評估。

今年的報告全面概​​述了2025年八大區域類別的發展趨勢，重點在於關鍵事件、競爭格局變化、價格趨勢和市場動態。此外，報告還按單焦點人工晶體、老花眼矯正晶體、散光矯正晶體和其他人工水晶體對六年期間（2019-2025年）的銷售業績進行了分類，從而更清晰地展現了各細分市場的成長情況以及高級產品組合的變化。

2026 年的報告新增了一個章節，檢驗人工智慧 (AI) 在人工水晶體) 設計中日益廣泛的應用及其對性能的潛在影響。報告還涵蓋了中小製造商採用的基於分銷商的打入市場策略的優勢和局限性（包括確定各地區的關鍵分銷商）、新興的人工水晶體材料（例如 Eyedeal 等基於 SIBS 的平台）以及更廣泛的市場因素，例如乾眼症管理如何最佳化人工水晶體術後效果，以及預計對白內障手術數量的潛在影響。

《2026 年人工水晶體市場報告》結合了對當前市場狀況的詳細分析和五年預測，以幫助制定策略、投資和競爭定位，從而提供全球人工水晶體市場的全面和數據驅動的觀點。

本報告基於 Market Scope 的專有模型和深入的行業洞察，識別出影響需求的趨勢，追蹤技術採用的發展，並重點介紹了在競爭日益激烈和創新主導的市場中決定成功的因素。

本報告將市場細分為 11 個不同的 IOL 類別（通用單焦點、增強型單焦點/中程最佳化單焦點、散光、PC 散光、雙焦點、三焦點、擴展景深 (EDOF)、EDOF 多重焦點混合型、調節型、術後可調型和有晶體眼 IOL），從而分析市場，清楚地展示了成長發生在哪裡以及高階市場如何繼續發展。

此外，本報告分析了 40 家主要企業，深入分析了它們的產品系列、戰略定位、競爭優勢和未來前景，提供了與競爭對手進行基準比較以及在全球 IOL 市場中識別商機所需的必要資訊。

目錄：

《2026 年人工水晶體市場報告》透過對八個主要地區的白內障和人工水晶體市場進行可操作的分析，提供了前所未有的全球展望，該分析整合了手術需求、技術採用和競爭趨勢。

範圍：

  • 全球白內障發病率和手術數量（目前估計值、預測值和5年預測值）
  • 雙側白內障同期手術的採用趨勢
  • 老花眼、屈光不正矯正和屈光水晶體置換術的角色轉變。
  • 按類型和地區對老花眼矯正型人工水晶體（PC-IOL）進行詳細預測。
  • 各國/地區單視及微單視策略實施情形
  • 美國白內障和屈光醫師的概況和臨床決策
  • 報銷趨勢及其對手術方案和高階人工水晶體應用的影響。
  • 對新興高階人工水晶體技術和產品改進的分析
  • 深入分析人工水晶體注射器市場及其在手術流程中的作用
  • 全球商業策略展望，包括 30 個主要國家的銷售和分銷網路。

這項綜合分析清楚地展現了當前全球人工水晶體(IOL) 市場的市場狀況以及成長機會所在。

簡介目錄

What's New:

The "2026 IOL Market Report" is our most comprehensive and strategically insightful edition to date, featuring deeper regional analysis, new technology intelligence, and broader evaluation of the structural forces reshaping the global cataract market.

This year's edition enhances all eight regional categories with a comprehensive recap of 2025, highlighting key events, competitive shifts, pricing dynamics, and market trends. In addition, a six-year revenue history (2019-2025) breaks out sales by monofocal, presbyopia-correcting, toric, and other IOLs to provide clearer visibility into segment-level growth and premium mix evolution.

The 2026 report also introduces new sections examining the growing use of artificial intelligence in PC-IOL design and its potential impact on performance; the advantages and limitations of distributor-based go-to-market strategies used by small- and mid-sized manufacturers (including identification of key distributors across all regions); emerging IOL materials such as SIBS-based platforms like Eyedeal; and broader market factors, including dry eye management to optimize IOL outcomes and the potential effect of an expected ophthalmic workforce shortage on cataract surgery volumes.

The "2026 IOL Market Report" delivers a comprehensive, data-driven view of the global intraocular lens market, combining detailed analysis of today's landscape with five-year forecasts designed to inform strategy, investment, and competitive positioning.

Built on Market Scope's proprietary models and deep industry insight, the report identifies the trends shaping demand, tracks shifts in technology adoption, and highlights the factors that will define success in an increasingly competitive and innovation-driven market.

The analysis segments the market across 11 distinct IOL categories-commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs- to provide a clear view of where growth is occurring and how the premium market continues to evolve.

In addition, the report profiles 40 leading companies, offering insight into their product portfolios, strategic positioning, competitive strengths, and future outlook to provide you with the intelligence needed to benchmark competitors and identify opportunities in the global IOL market.

Contents:

The "2026 IOL Market Report" provides an unprecedented global view of the cataract and intraocular lens market, spanning eight key regions and combining procedure demand, technology adoption, and competitive dynamics into a single, actionable analysis.

Coverage includes:

  • Global cataract incidence and surgical volume, with current estimates and five-year forecasts
  • Adoption trends for simultaneous bilateral cataract surgery
  • The evolving role of presbyopia, refractive error correction, and refractive lens exchange
  • Detailed forecasts for presbyopia-correcting IOLs (PC-IOLs) by type and region
  • Adoption of monovision and mini-monovision strategies by country/region
  • Profiles of US cataract and cataract/refractive surgeons and their clinical decision-making
  • Reimbursement trends and their impact on procedure mix and premium adoption
  • Analysis of emerging premium IOL technologies and product enhancements
  • Insights into the IOL injector market and its role in surgical workflow
  • A global view of commercial strategy, including sales and distribution coverage across 30 major countries

This integrated analysis provides a clear understanding of where the market stands today and where growth opportunities are emerging across the global IOL landscape.